BioMedomics Celebrates Sickle Cell Awareness Month

September is National Sickle Cell Awareness Month. Sickle cell disease is an inherited disease that distorts soft and round red blood cells and turns them into hard, crescent shaped cells. These distorted red blood cells can cause those affected to experience extreme pain and often requires numerous blood transfusions to increase the number of normal red blood cells in the body and unblock blood vessels. According to the American Red Cross, a patient with sickle cell disease may need up to 100 units of blood each year to treat complications from the disease.

BioMedomics would like to reaffirm our commitment to improving the quality of life and health outcomes of those affected by sickle cell disease. We encourage everyone to be part of this international effort to increase awareness about sickle cell disease and sickle cell trait. Individuals and organizations can join our efforts by donating blood, engaging elected officials for proclamations, and distributing educational information to dispel the myths about sickle cell disease.

BioMedomics™ Sickle SCAN® is a multiplexed, qualitative, point-of-care immunoassay to aid in the rapid diagnosis of sickle cell disorders. The test is made up of three indicators which detect the presence of hemoglobin A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell disease samples.

  • No electricity or instrumentation required
  • Combined sensitivity and specificity of >99%
  • Results in 5 minutes
  • Suitable for newborn screening
  • Ships worldwide

For more information, please email info@biomedomics.com. To place an order, please email sales@biomedomics.com.

BioMedomics, Inc. Recertified for ISO 13485

BioMedomics, Inc. is proud to announce that the BSI Group of America has accredited and recertified our ISO 13485:2016 certification.

The certification of compliance with ISO 13485:2016 recognizes that the policies, practices and procedures of our company ensure consistent quality in the product and services we provide our clients. With this certification, our clients can be confident that BioMedomics, Inc. is dedicated to maintaining the highest efficiency and responsiveness in achieving our ultimate goal – guaranteed client satisfaction.

BioMedomics, Inc. is certified as meeting the requirements of ISO 13485:2016 for the following activities:

The design, development and manufacture of in-vitro diagnostic medical devices used in the detection of hemoglobin disorders and/or adaptive immune responses including laboratory and point-of-care in-vitro diagnostic medical devices.

To maintain our certification, we will perform audits to ensure compliance and to assess initiatives for continued improvement. Our clients can be confident that BioMedomics, Inc. will continue to provide the high-quality products and services they have come to expect well into the future.

Article about BioMedomics’s COVID-19 IgM/IgG Rapid Antibody Test Awarded as Top Cited Paper in Journal of Medical Virology!

An article about BioMedomics’s COVID-19 IgM/IgG Rapid Antibody Test that several employees of BioMedomics, Inc., worked on has been awarded as one of the top cited papers 2019-2020 by the Journal of Medical Virology!

The Journal of Medical Virology is a peer-reviewed medical journal covering fundamental and applied research in regard to viruses that effect humans.

Congratulations to our team members for their contribution towards educating the public on the importance and effectiveness of COVID-19 antibody tests! To read the article, click here.

 

 

BioMedomics, Inc.’s ISO 13485 Certification Granted Expansion

BioMedomics, Inc. is proud to announce its ISO 13485:2016 certificate has expanded in scope to include the design, development and manufacturing of COVID-19 rapid tests.  The certification is accredited by BSI Group America.

The certification of compliance with ISO 13485:2016 recognizes that the policies, practices and procedures of our company ensure consistent quality in the product and services we provide our clients. With this certification, our clients can be confident that BioMedomics, Inc. is dedicated to maintaining the highest efficiency and responsiveness in achieving our ultimate goal – guaranteed client satisfaction.

BioMedomics, Inc. is certified as meeting the requirements of ISO 13485:2016 for the following activities:

The design, development and manufacture of in-vitro diagnostic medical devices used in the detection of hemoglobin disorders and/or adaptive immune responses including laboratory and point-of-care in-vitro diagnostic medical devices.

To maintain our certification, we will perform audits to ensure compliance and to assess initiatives for continued improvement. Our clients can be confident that BioMedomics, Inc. will continue to provide the high-quality products and services they have come to expect well into the future.

We believe that our decision to expand our ISO certification to include our COVID-19 product line is a proactive one that not only anticipates the demands of our clients, but also demonstrates our commitment to providing quality services to all our clients.

COVID-19 IgM/IgG Rapid Test Approved by INVIMA in Colombia!

We are excited to announce that the National Institute for Food and Drug Surveillance (INVIMA) has given BioMedomics, Inc. authorization to sell and distribute our COVID-19 IgM/IgG Rapid Test in Colombia!

We have partnered with Piso Pélvico-GILMEDICA S.A. to assist with distributing our product to customers. For sales requests in Colombia, please contact Mr. Julián Potes by email (julian.potes@gilmedica.com) or phone (+57 318 827 49 94).

BioMedomics’s COVID-19 IgM/IgG Rapid Test is one of the first and most accurate COVID-19 antibody rapid tests on the market, winning over competitor testing methods with:

  • Fastest test result of 10-15 minutes
  • Highest combined sensitivity/specificity (100%/~99%)
  • Intuitive visual interpretation
  • No special equipment needed

For information or questions about our COVID-19 IgM/IgG Rapid Test, please email info@biomedomics.com

To receive a quote and place an order, please email sales@biomedomics.com

*Not available for sale within the USA.